Speaker illustration

Associate Professor Gianluigi Pironti

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology

Dr. Pironti works as Ass. Professor at Karolinska Institutet Dept. of Cardiology leading projects focused on heart disease and associated co-morbid clinical conditions such as heart failure, cardiomyopaties, ischemic heart disease, diabetes and inflammation. His studies are oriented in discovering new molecular mechanisms and therapies to reduce cardiac fibrosis and improve cardiomyocytes' contractility. From 2018 to 2019 he worked as Assistant Professor at Karolinska Institutet, Integrated Cardio Metabolic Center (ICMC), leading research projects aimed to develop new therapies for cardiovascular diseases models using stem cell, modified mRNA, tissue engineered heart patches. He was also coordinating and conducting projects for joint collaboration with industry partners (Astra Zeneca). From 2012 to 2015 he was a post doc fellow at Duke University (NC/US) studying mechanism of G Protein Coupled Receptors (GPCRs) signaling in normal and failing hearts involving exosomes.

Impaired myofibrillar contractile function in a mouse model of rheumatoid arthritis is linked to increased citrullination of a-actin

Event: Heart Failure 2021

Topic: Experimental Heart Failure

Session: ePoster session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb